BODIPY‐Based Photodynamic Agents for Exclusively Generating Superoxide Radical over Singlet Oxygen
Authors:
- 6 July 2021
- journal article
- research article
- Published by Wiley in Angewandte Chemie
- Vol. 133 (36) , 20065-20073
Abstract
Developing Type‐I photosensitizers is considered as an efficient approach to overcome the deficiency of traditional photodynamic therapy (PDT) for hypoxic tumors. However, it remains a challenge to design photosensitizers for generating reactive oxygen species by the Type‐I process. Herein, we report a series of α,β‐linked BODIPY dimers and a trimer that exclusively generate superoxide radical (O2−.) by the Type‐I process upon light irradiation. The triplet formation originates from an effective excited‐state relaxation from the initially populated singlet (S1) to triplet (T1) states via an intermediate triplet (T2) state. The low reduction potential and ultralong lifetime of the T1 state facilitate the efficient generation of O2−. by inter‐molecular charge transfer to molecular oxygen. The energy gap of T1‐S0 is smaller than that between 3O2 and 1O2 thereby precluding the generation of singlet oxygen by the Type‐II process. The trimer exhibits superior PDT performance under the hypoxic environment.Keywords
Funding Information
- National Natural Science Foundation of China (21525206, 21971023, 21688102)
This publication has 80 references indexed in Scilit:
- Recent progress in photosensitizers for overcoming the challenges of photodynamic therapy: from molecular design to applicationChemical Society Reviews, 2021
- Advanced Photosensitizer Activation Strategies for Smarter Photodynamic Therapy BeaconsAngewandte Chemie International Edition, 2018
- Advanced Photosensitizer Activation Strategies for Smarter Photodynamic Therapy BeaconsAngewandte Chemie, 2018
- Photodynamic therapy (PDT) of cancer: from local to systemic treatmentPhotochemical & Photobiological Sciences, 2015
- Photodynamic therapy of cancer: An updateCA: A Cancer Journal for Clinicians, 2011
- Photodynamic Therapy and the Development of Metal-Based PhotosensitisersMetal-Based Drugs, 2008
- Photodynamic therapy and anti-tumour immunityNature Reviews Cancer, 2006
- Mechanisms in photodynamic therapy: part two—cellular signaling, cell metabolism and modes of cell deathPhotodiagnosis and Photodynamic Therapy, 2005
- Photodynamic therapy for cancerNature Reviews Cancer, 2003
- Photodynamic TherapyJNCI: Journal of the National Cancer Institute, 1998